Yue ZHU

Ms. Yue ZHU


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2026 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
PDF file
MXManru Xu
Manru Xu
HGHanyue Gan
Hanyue Gan
FZFurong Zhong
Furong Zhong
MQMengyuan Qiao
Mengyuan Qiao
PRPan Ren
Pan Ren
WWWenbin WU
Wenbin WU
Prediabetes is characterized by its high global prevalence and significant risk of progression to diabetes. The current research focus lies in precise risk

24 April 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
FYFei Yu
Fei Yu
YZYue ZHU
Yue ZHU
NLNa Li
Na Li
QPQing Peng
Qing Peng
FYFanghang Ye
Fanghang Ye
XHXiaoyu Hu
Xiaoyu Hu
The sodium-taurocholate cotransporting polypeptide (NTCP) plays a critical dual role in liver function: maintaining bile acid (BA) enterohepatic circulation and acting as a receptor for the entry of hepatitis B and D viruses into hepatocytes. This review outlines the impact of various post-translational modifications (PTMs) of NTCP—including phosphorylation, oligomerization, ubiquitination, and glycosylation—on its dynamic regulatory network. These modifications coordinate the modulation of NTCP’s membrane localization, stability, conformational state, and protein interactions, precisely controlling its functions in BA uptake and viral invasion. Targeting this PTM network presents a promising strategy for next-generation therapies that selectively inhibit viral infection while preserving BA transport, overcoming the limitations of conventional inhibitors that indiscriminately disrupt virus–NTCP interactions. By synthesizing recent insights into NTCP PTM research, this article highlights its role as a central regulator of its bifunctional properties and reveals potential avenues for precision therapies in viral hepatitis, cholestasis, and related liver diseases. However, most existing evidence is derived from in vitro or cell-based models, whereas in vivo studies and clinical validation remain limited; thus, the translational feasibility of strategies targeting post-translational modifications of NTCP still requires further investigation.